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ABSTRACT 
Herbal products encompass a variety of preparations of plant origin 
that are the oldest form that humanity has been using to treat diseases, 
a practice that has grown enormously in the last decade. The aim of 
this study is to determine the natural medicinal products regulatory 
status of the main health authorities worldwide, to be used as a basis 
for improvement and optimization of legislation. Materials and 
Methods: A comparative study assessment of the natural medicinal 
products regulatory status in major health authorities in 2015, 
searching database of various government health agencies around the 
world, using keywords to find case law, regulations and laws on the 
subject and by information triangulation technique it was established 
the current regulatory situation. Results: It is well known that herbal 
products are not completely free of side effects, so is surprising that  very few countries have 
a national policy to regulate and promote the safety and quality of medicinal plant materials. 
Depending on the country concerned, a herbal product could be defined as food, dietary 
supplement or herbal medicine. This disparity in the regulations that apply in different 
countries, influences access to products and international distribution plus it is not guaranteed 
that natural medicinal products meet the requirements of safety, efficacy and quality. 
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INTRODUCTION 
The use of herbs for medicinal purposes is an ancient custom and, either by an idealization of 
nature or the poverty, using plants to cure various diseases is a practice that has been 
increasing in recent years. The number of higher plants cataloged on earth is about 250,000 
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and it is estimated that between 35 000 and 70 000 species have been used by some cultures 
for medicinal purposes.
[1, 2]
 
 
In developed countries, the widespread use of herbal medicine was reduced at the end of the 
twentieth century due to the development and production of synthetic drugs. However, in 
recent decades, herbal medicine has begun to be increasingly used, even in industrialized 
countries.
[3]
 
 
The World Health Organization (WHO) defines as finished medicinal herbal medicines and 
labeled products whose active ingredients are aerial or underground parts of plants or other 
plant materials or combinations thereof, unwrought or as plant preparations. Plant material 
includes juices, gums, fatty oils, essential oils or any other substances of this nature
[3]
 
understood. 
 
It is estimated that about 25% of prescribed drugs worldwide are derived from plants and are 
in use 121 active compounds from them. Of the total of 252 drugs on the essential drug list of 
the WHO, 11% is exclusively of vegetable origin. Almost 80% of the population of Africa 
and Asia depends on traditional medicine for primary health care.
[4]
 
 
According to WHO, the percentage of the population that has used such drugs at least once is 
48% in Australia, 31% in Belgium, 70% in Canada, 42% in the US and 49 % in France. Also 
in Japan 85% of doctors prescribe medicine not only modern but also traditional medicinal 
herbs which are covered by health insurance. In China, traditional medicine accounts for 
about 40% of all health care provided. While in Africa, more than 80% of the population 
depends on herbal medicines. In Latin America traditional medicine has been used by 71% of 
the Chilean population and 40% of the Colombian population.
[5]
 
 
The herbal products are not completely free of side effects. Clinical studies have shown that 
the occurrence of undesirable side effects is possible with the use of herbal medicines; these 
effects could be due to the inadvertent use of the wrong plant species, adulteration with other 
medicines, contamination with toxic substances undeclared overdose, misuse by consumers 
and concomitant use with other drugs, causing adverse drug interactions.
[4]
 
 
It is well known that there are many contaminants and residues in medicinal plants that can 
cause harm to consumers, such as radionuclides, toxic metals or microorganisms. Some arise 
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from past or present use of agents or materials that pollute the environment and then to 
plants, such as emissions from factories or residues of certain pesticides.
[6]
 
 
Despite its existence and continued use for many centuries, and its popularity and extensive 
use of the last decade, traditional medicine has not been officially recognized in most 
countries. Consequently, education, training and research in this area has not been accorded 
due attention and support.
[5]
 
 
The practice of traditional medicine vary widely from country to country and from region to 
region, as they are influenced by factors such as culture, history, personal attitudes and 
philosophy.
[5]
 
 
Policies to regulate herbal medicines must have 3 main objectives
[7]
 
1. minimize the damage caused by dangerous products, 
2. increasing medical and economic benefits of using herbs, and 
3. to rationalize the use of herbs based on scientific evidence. 
 
MATERIALS AND METHODS 
This paper is a worldwide comparative-diagnostic study on the natural medicinal products 
regulatory status in 2015, for this a search was conducted in the databases of various 
government health agencies around the world, using key to finding the law, regulations and 
laws in the field, using the technique of triangulation of information to establish the current 
regulatory situation words. 
 
As a reference for the major health authorities to investigate the information in "National 
Policy on Traditional Medicine and Regulation of Herbal Medicines - Report of a WHO 
Global Survey"
[8]
 was used in 2005, which states where there is a regulatory status of natural 
medicinal products, secondly it was determined which is the most recognized at regional 
level, with respect to the population under their jurisdiction, and health levels measured from 
its infant mortality rate and life expectancy health Authority, with priority given to submit 
lower infant mortality and increased life expectancy, finally the information collected was 
classified by region and triangle to conclude an overall regulatory status. 
 
RESULTS AND DISCUSSION 
Legislative controls regarding medicinal plants have not evolved around a structured model 
control. There are different ways that countries define plants or herbs or products derived 
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from the same drugs, and some countries have adopted different approaches to licensing, 
distribution, manufacturing and marketing to ensure their safety, quality and efficacy ; in fact 
according to the survey "National Policy on Traditional Medicine and Regulation of Herbal 
Medicines - Report of a WHO Global Survey" of 2005, only 92 countries have a national 
policy in this area, representing 65% of the member states. Depending on the country 
concerned, an herbal product could be defined as food, dietary supplement or herbal 
medicine. This disparity in the regulations that apply in different countries affects access to 
products and international distribution.
[8, 9]
 
 
A summary of the regulatory situation in some regions is as follows 
World Health Organization (WHO) 
The World Health Organization is the governing body of world health policies, therefore, the 
definitions of this entity as a reference point used to establish the comparative analysis of 
regulatory status in other regions of the planet. 
 
It is defined as traditional medicine, "the entire set of knowledge, skills and based on theories, 
beliefs and experiences indigenous to different cultures practices, whether explicable or not, 
used for health maintenance and prevention, diagnosis, improvement or treatment of physical 
or mental illness" 
 
The definition of herbal medicine "includes herbs, herbal materials, herbal preparations and 
finished herbal products, that contain as active ingredients parts of plants, or other plant 
materials, or combinations of these elements." 
 
Herbs: include gross, such as leaves, flowers, fruits, seeds, stems, wood, bark, roots, rhizomes 
and other plant parts, whole, fragmented or powdered plant materials. 
 
Other important definitions established by WHO document drawn General Guidelines for 
Methodologies on Research and Evaluation of Traditional Medicine.
[10]
 
 
"Herbal Materials: includes, in addition to herbs, fresh juices, gums, fixed oils, essential oils, 
resins and dry powders of herbs. In some countries these products can be processed by 
various local procedures, such as steaming, roasting or stir-baking with honey, alcoholic 
beverages or other materials." 
 
"Herbal Preparations are the basis for finished herbal products and may consist of crushed or 
ground herbal materials, or extracts, tinctures and fatty oils of herbal materials. They 
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produced by extraction, fractionation, purification, concentration and other biological or 
physical processes. They also include preparations made by steeping or heating herbal 
materials in alcoholic beverages or honey or other materials." 
 
"Finished herbal products: consist of herbal preparations made from one or more herbs. If 
you use more than one herb, you can also use the term 'blend of herbal products. "Finished 
herbal products and mixture herbal products may contain excipients in addition to the active 
ingredients. However, not considered to be herbal finished or in admixture products that have 
been added chemically defined active substances, including synthetic compounds or isolated 
constituents of herbal materials." 
 
The description of the regulatory status of natural medicinal products in different regions of 
the planet now be used. 
 
Asia: In most Asian countries traditional medicine is used regularly by a high percentage of 
the population and are often used in combination with western medicine; health authorities in 
different countries have made efforts to establish laws and regulations to ensure the quality, 
safety and efficacy of these medicines, and also define the professional profile and technical 
expertise for trade and dispensing of pharmaceuticals. In Japan, a country where the per 
capita consumption in natural products is the highest in the world, this class of drugs are 
regulated in the same way as western medicines and must present data from clinical trials of 
three phases. Moreover, in the Republic of Korea only standardized medicinal plants can be 
distributed legally. In Hong Kong, herbal remedies are subject to import and export controls, 
quality and advertising; for which it specified that traditional Chinese medicine cannot be 
advertised for certain diseases that require proper diagnosis, such as cardiovascular 
disease.
[11]
 
 
In 1993 the Japanese Standards for Herbal Medicines, which contains 248 articles were 
published: 165 Japanese Pharmacopoeia (XII) and 83 of the Japanese Codex; herbal medicine 
and materials or herbal ingredients listed in the Standards should be used to make or imported 
herbal medicines. 
 
The Pharmaceutical Education Center of Japan issues a certificate for pharmacists 
specializing in Kampo medicines and herbal materials according to their own qualification 
criteria. This certification must be renewed every three years. 
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Moreover, the Chinese government has strengthened its commitment to the integration of 
traditional and allopathic medicine on several occasions. Article 21 of the Constitution of the 
People's Republic of China, adopted in 1982, promotes traditional Chinese medicine and 
allopathic. The Office of Traditional Medicine was established as part of the Central Health 
Administration in 1984. In 1986, the State Administration of Traditional Chinese Medicine 
was established.
[12]
 
 
Oceania 
In 1974, the Australian Parliament created the Research Committee of chiropractic, 
osteopathy, homeopathy and naturopathy. The Committee published an extensive report in 
1977. 
 
In 2000, the Therapeutic Goods Administration established the Guidelines on levels and 
types of data required to support statements about therapeutic products. The Evaluation 
Committee of Complementary Medicines recognizes two types of evidence to support claims 
on therapeutic products: scientific evidence and traditional use. The extent of evidence 
needed depends on the claims made by the product. For the Committee, the traditional use 
refers to evidence in writing or orally recorded for a substance that has been used for three or 
more generations for health-related purposes. The regulations include provisions for the use 
of drugs that combine a number of traditions, and the use of treatments are recent 
modifications of traditional therapies. Traditional therapies include traditional Chinese 
medicine, traditional ayurvedic medicine, traditional European herbal medicine, traditional 
homeopathic medicine, aromatherapy, and other traditional medicines.
[12]
 
 
Africa 
Considering the high value of medicinal plants for primary health care, African countries 
began in 1985, the development of a legal framework for the practice of traditional medicine 
and adopting control measures for the plant material, developing campaigns public 
information and providing professional education to ensure proper and safe use of these 
products. At present, work on the establishment of collaborative centers of excellence / WHO 
for research and development of traditional medicines used in the treatment of priority 
diseases and the promotion of preclinical research and clinical evaluation, development, 
production Local and marketing of traditional medicines standardized.
[13]
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In South Africa the National Department of Agriculture regulates traditional drugs through 
the National Commission on Plant Genetic Resources, which is a member of a traditional 
healer. The National Department of Health produced the National Drug Policy. For the 
purposes of the implementation of the National Drug Policy regarding traditional medicines, 
the National Department of Health created the National Reference Center for traditional 
medicines. Traditional medicines are included in the section Drug Policy Programme for 
Reconstruction and Development of the Government. 
 
In 1998, Parliament passed Law 132, the Regulatory Authority of drugs and medical devices, 
including registration and regulation of traditional medicines. provisions to be applied when 
registering allopathic medicines either, traditional and complementary / alternative sets. This 
is done by setting up committees of independent experts for the two main types of medicine. 
In the case of traditional medicines, issues of safety and quality take precedence over claims 
of effectiveness. The aim is to regulate and do not prevent access.
[12]
 
 
Europe 
In 1989 the European Scientific Cooperative on Phytotherapy (ESCOP for short) was 
established with the purpose of establishing the criteria for the evaluation of herbal 
medicines, support scientific research and contribute to the acceptance of herbal medicine in 
Europe. Europe also has, with a system of mutual recognition of decisions marketing 
authorization to allow free movement of medicines in the market of the European Union.
[14]
 
In order to protect public health while ensuring the free movement of medicinal herbal within 
the European Union, the way drugs herbal are registered and marketed has been in change 
since 2004 and to date. 
 
Is intended for evaluation of applications for marketing all Member States can refer to a 
single set of information on a plant substance or the herbal preparation that includes the 
therapeutic uses and safe conditions of use recommended. a subcategory of drugs also 
introduces herbal for which must be demonstrated safety and efficacy.
[15]
 
 
In the European Union the herbal medicines can register in three ways 
As a result of traditional medicinal use accepted on the basis of data on safety and efficacy 
sufficient, it is granted a traditional use (simplified registration procedure) by a Member 
State. 
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As a result of well-established medicinal use, it is demonstrated by scientific literature that 
the active ingredients have been well known medicinal use within the Union for at least ten 
years, with recognized efficacy and an acceptable level of safety. As a result the product is 
granted a marketing authorization usually by a Member State or the European Medicines 
Agency. 
 
A product can be authorized after evaluation of an application for marketing authorization 
consisting of only studies of safety and effectiveness conducted by the company ("stand 
alone") or a combination of own studies and bibliographic data ('mixed') application. As a 
result the product is granted a marketing authorization by a Member State or the Agency 
through the centralized procedure if all requirements are met.
[16]
 
 
Regardless of the regulatory pathway to market access, the quality of herbal medicine should 
always be shown.
[17]
 
 
In some countries like France, Belgium, Spain, Switzerland, medicinal plants are classified in 
lists and registration requirements vary according to the list in which the plant is located, also 
changes the mode and site of authorized sales: prescription medical, without prescription, sale 
only in pharmacies or other point of sale.
[11]
 
 
In Belgium for example, combinations of more than three floors of a single list or if the plants 
belong to different lists are accepted. They also have available a list of indications for 
traditional uses of different plant groups. 
 
Moreover, in Germany, Austria, Bulgaria, Ireland; products containing ingredients herbal 
medicines are considered when labeling or accompanying documents indicate prevention, 
cure or remedy, or when any of the ingredients is recognized as having medicinal properties. 
For the record must be submitted documentation with pharmaceutical and chemical 
characteristics, application, usual dose, mechanism of action, side effects and interactions 
with other medications. The quality control is performed according to the European 
Pharmacopoeia.
[13]
 
 
It is possible to market natural products that do not have sufficient scientific evidence of 
efficacy under the name "traditional use" quality records "traditional" products are not 
checked by the health authority and the person who sells is not allowed to give 
recommendations on the use of the products. 
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America 
In 1994, the Congress of the United States of America, approved the law Dietary Supplement 
Health and Education Act (DSHEA), to regulate botanicals. DSHEA classifies herbs, 
vitamins, minerals and amino acids as nutritional or food supplements and allows these 
products to be marketed without evidence of efficacy, safety or quality, provided they are not 
recommended to diagnose, treat, cure or prevent any disease. As a result, consumers have no 
guarantee of the quality of the product they are consuming. Moreover, in contrast to 
prescription drugs, the Federal Food and Drug Administration must first demonstrate that a 
herbal preparation is not safe before it can be withdrawn from the market.
[18, 19]
 
 
Due to the problems presented with plants such as St. John's wort; Hypericum perforatum, 
echinacea and ephedra genus, in 2006 the Law dietary supplement and Consumer Protection 
drug without a prescription, which requires manufacturers, packers or distributors of 
supplements reporting of approved serious adverse events FDA. Serious adverse events are 
defined as death, a life-threatening event, hospitalization, persistent or significant disability or 
incapacity, congenital anomaly or birth defect or an adverse event requiring medical or 
surgical intervention. These reports are used to identify adverse trends and help alert the 
public about the security problems.
[20]
 
 
Unlike the United States, Canada, natural medicinal products are regulated as drugs and there 
is a lot of natural products with therapeutic indications that are legally marketed.
[19]
 
 
Moreover, the law in Argentina does not differentiate between natural medication and 
chemical and drug since 1993, the obligation to register drugs of natural origin was 
established.
[21]
 
 
The herbalists are authorized to sell the plant drug mixtures but also must have a pharmacist 
as technical director. It is important to mention that people who plant and harvest medicinal 
plants must be authorized by the Ministry of Health.
[22]
 
 
Always in South America, in August 1992, it was created in Chile, the Traditional Medicine 
Unit to integrate traditional medicine with proven efficacy in health programs, and help 
establish their practice. Natural products are classified.
[23]
 
- Medicines to cure, relieve or prevent diseases 
- Food products with medicinal and therapeutic properties 
- Food products with nutritional purposes 
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According to the regulation, control of medicines, food and cosmetics products for medical 
use, herbal products with therapeutic indications or dosage recommendation are considered 
drugs. Its distribution is restricted to pharmacies and drugstores. 
 
In Colombia since 1995 the Government issued a decree establishing the procedure for 
registration of natural products with therapeutic indications and the required technical 
documentation on manufacturing processes, quality control, and if toxicity studies is required 
and monographs material, including its traditional use, application method, dosage, 
contraindications, adverse reactions and literature. With special authorization selling 
individually packaged plant material is allowed and not mixed, as long as you can not declare 
a therapeutic activity.
[24]
 
 
In Cuba natural products are part of the national health system are prescribed and dispensed 
in community pharmacies and hospital, and there is an herbal form of apitherapy, there 
numerous national and regional natural products industry and quality standards. 
 
In 1992, the Ministry of Health officially recognized homeopathic products. A good standard 
manufacturing practice for the manufacture of homeopathic remedies has been accepted. In 
1995, the Traditional Medicine Program was instituted, giving priority to the cultivation of 
medicinal plants, professional education, research of traditional medicine, and the integration 
of traditional medicine into the national health system.
[25]
 
 
There is a program of regional companies that distribute natural medicinal products 
standardized according to the national form. 
 
In Central America, the Technical Committee of Standardization and Technical Regulations 
through entities Standardization and Technical Regulations of the countries of the region, 
made up of representatives of the academic, consumer, private enterprise and government; 
are the bodies responsible for carrying out the study or adoption of Technical Regulations and 
as for natural medicinal products, in 2013 went into effect three Technical Regulations 
RTCA 11.03.64: 11 Requirements for Health Registry " 
RTCA 03.11.56: 09 Quality Verification 
RTCA 11.04.41: 06 Labeling Requirements. 
 
These regulations apply to natural medicinal products for human use marketed in the State 
party in Central America and in them the conditions and requirements under which sanitary 
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registration will be granted the analytical tests are established, and; physicochemical and 
microbiological tests, to be carried out to verify the quality of natural medicinal products for 
human use by the health authority in each country. The technical evaluation also revising the 
labeling included.
[26]
 
 
For purposes of these regulations is meant as a medicinal natural product that processing, 
industrial and product labeling with medicinal properties, which contains in its formulation 
ingredients derived from plant, animal, mineral or mixtures thereof. It may contain excipients 
in addition to the natural material. Products that includes active substances chemically 
synthesized or isolated from natural material as responsible for the synthesis pharmacological 
activity, are not considered as natural medicines. Regarding the dosage form or route of 
administration, they are all accepted while its proven safety and efficacy, except for those 
intended for ophthalmic and parentally use. 
 
Natural products for medicinal purposes can be marketed through two ways: selling product 
prescription or over the counter product. 
 
The documentation to be submitted for the sanitary registration, whose term is five years, 
including a monograph with the technical scientific description of the safety profile and 
effectiveness, according to the level of evidence of a medicinal natural product, the 
Certificate of Good Practices manufacturing, each of the establishments involved in the 
manufacture of the product, qualitative and quantitative formula, efficacy and safety 
information and labeling of packaging or primary, secondary and package insert. 
 
The traditional use must be supported by documentary evidence stating that they natural drug 
that is used in a product, has been used for three or more decades for medicinal purposes. 
 
CONCLUSIONS 
Regulation and national and international health controls should ensure that natural products 
meet the requirements of safety, efficacy and quality. 
 
It should be remembered that natural products subjected to industrial processes, must meet 
standards or quality guidelines for cultivation, collection and processing, to avoid that during 
the process of production and marketing contamination, adulteration or deterioration is 
generated, which jeopardize the health of the population. 
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Therefore, the health authorities must maintain standards and controls necessary to minimize 
the damage caused by dangerous products and rationalize the use of substances with 
pharmacological activity based on scientific and traditional evidence. The documentation on 
the scientific evidence on the safety and efficacy of these products as well as compliance with 
quality processes, by companies should be available to the entire population and be subject to 
verification by the health authorities, so that in the not too distant future can be sold only high 
quality herbal products, and traditionally scientifically proven. 
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